Zealand Pharma (Denmark) Analysis
| ZEAL Stock | DKK 723.00 15.50 2.10% |
Zealand Pharma AS is overvalued with Real Value of 592.86 and Hype Value of 723.0. The main objective of Zealand Pharma stock analysis is to determine its intrinsic value, which is an estimate of what Zealand Pharma AS is worth, separate from its market price. There are two main types of Zealand Pharma's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Zealand Pharma's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Zealand Pharma's stock to identify patterns and trends that may indicate its future price movements.
The Zealand Pharma stock is traded in Denmark on Copenhagen Exchange, with the market opening at 09:00:00 and closing at 17:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Denmark. Zealand Pharma is usually not traded on Christmas Day, Boxing Day, New Year 's Day, Maundy Thursday, Good Friday, Easter Sunday, Easter Monday, GreatPrayerDay. Zealand Stock trading window is adjusted to Europe/Copenhagen timezone.
Zealand |
Zealand Stock Analysis Notes
About 56.0% of the company outstanding shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 0.31. Zealand Pharma AS recorded a loss per share of 23.13. The entity had not issued any dividends in recent years. Zealand Pharma AS, a biotechnology company, engages in the discovery, design, and development of peptide-based medicines in Denmark. The company was founded in 1997 and is headquartered in Copenhagen, Denmark. Zealand Pharma operates under Biotechnology classification in Denmark and is traded on Copenhagen Stock Exchange. It employs 360 people. For more information please call Adam MD at 45 88 77 36 00 or visit https://www.zealandpharma.com.Zealand Pharma AS Investment Alerts
| Zealand Pharma AS generated a negative expected return over the last 90 days | |
| The company reported the revenue of 292.57 M. Net Loss for the year was (1.02 B) with profit before overhead, payroll, taxes, and interest of 173.75 M. | |
| Zealand Pharma AS has accumulated about 1.28 B in cash with (1.21 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 29.66. | |
| Roughly 56.0% of the company outstanding shares are owned by institutional investors |
Zealand Market Capitalization
The company currently falls under 'Large-Cap' category with a current market capitalization of 11.16 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Zealand Pharma's market, we take the total number of its shares issued and multiply it by Zealand Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 27th of November, Zealand Pharma maintains the Market Risk Adjusted Performance of (0.20), standard deviation of 2.93, and Mean Deviation of 2.2. Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of Zealand Pharma AS, as well as the relationship between them.Zealand Pharma AS Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Zealand Pharma middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Zealand Pharma AS. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Zealand Pharma Outstanding Bonds
Zealand Pharma issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Zealand Pharma AS uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Zealand bonds can be classified according to their maturity, which is the date when Zealand Pharma AS has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View |
Zealand Pharma Predictive Daily Indicators
Zealand Pharma intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Zealand Pharma stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 15928.63 | |||
| Daily Balance Of Power | (0.36) | |||
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 724.0 | |||
| Day Typical Price | 723.67 | |||
| Market Facilitation Index | 2.0E-4 | |||
| Price Action Indicator | (8.75) | |||
| Period Momentum Indicator | (15.50) |
Zealand Pharma Forecast Models
Zealand Pharma's time-series forecasting models are one of many Zealand Pharma's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Zealand Pharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Zealand Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Zealand Pharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Zealand shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Zealand Pharma. By using and applying Zealand Stock analysis, traders can create a robust methodology for identifying Zealand entry and exit points for their positions.
Zealand Pharma AS, a biotechnology company, engages in the discovery, design, and development of peptide-based medicines in Denmark. The company was founded in 1997 and is headquartered in Copenhagen, Denmark. Zealand Pharma operates under Biotechnology classification in Denmark and is traded on Copenhagen Stock Exchange. It employs 360 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Zealand Pharma to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Backtesting Now
Portfolio BacktestingAvoid under-diversification and over-optimization by backtesting your portfolios |
| All Next | Launch Module |
Other Information on Investing in Zealand Stock
Zealand Pharma financial ratios help investors to determine whether Zealand Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Zealand with respect to the benefits of owning Zealand Pharma security.